Long-term effects of a PPAR-gamma agonist, pioglitazone, on neointimal hyperplasia and endothelial regrowth in insulin resistant rats (Q79399948)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17141574%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

title

Long-term effects of a PPAR-gamma agonist, pioglitazone, on neointimal hyperplasia and endothelial regrowth in insulin resistant rats (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17141574%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

1 reference

Cyrus V Desouza

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17141574%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

Moira Gerety

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17141574%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

Frederick G Hamel

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17141574%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

publication date

7 October 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17141574%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

number of pages

7

1 reference

based on heuristic

inferred from page(s)

published in

Vascular Pharmacology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17141574%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

volume

46

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17141574%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17141574%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

page(s)

188-194

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17141574%20AND%20SRC:MED&resulttype=core&format=json

Pioglitazone enhances cytokine-induced apoptosis in vascular smooth muscle cells and reduces intimal hyperplasia

22 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.10.001

Local delivery of vascular endothelial growth factor accelerates reendothelialization and attenuates intimal hyperplasia in balloon-injured rat carotid artery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.10.001

Accelerated restitution of endothelial integrity and endothelium-dependent function after phVEGF165 gene transfer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.10.001

Peroxisome proliferator-activated receptors in the cardiovascular system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.10.001

Vascular permeability factor accelerates endothelial regrowth following balloon angioplasty

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.10.001

The mitogenic effect of 17beta-estradiol on in vitro endothelial cell proliferation and on in vivo reendothelialization are both dependent on vascular endothelial growth factor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.10.001

Differential effects of peroxisome proliferator activator receptor-alpha and gamma ligands on intimal hyperplasia after balloon catheter-induced vascular injury in Zucker rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.10.001

Neointimal hyperplasia and vascular endothelial growth factor expression are increased in normoglycemic, insulin resistant, obese fatty rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.10.001

Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.10.001

Vascular endothelial growth factor synthesis in vascular smooth muscle cells is enhanced by 7-ketocholesterol and lysophosphatidylcholine independently of their effect on nitric oxide generation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.10.001

Nontraditional risk factors for cardiovascular disease in diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.10.001

Thiazolidinediones, peroxisome proliferator-activated receptor gamma agonists, regulate endothelial cell growth and secretion of vasoactive peptides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.10.001

Risk factor groupings related to insulin resistance and their synergistic effects on subclinical atherosclerosis: the atherosclerosis risk in communities study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.10.001

Expression of inducible nitric oxide synthase after endothelial denudation of the rat carotid artery: role of platelets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.10.001

Kinetics of smooth muscle cell proliferation and intimal thickening in a pig carotid model of balloon injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.10.001

Insulin-resistant prediabetic subjects have more atherogenic risk factors than insulin-sensitive prediabetic subjects: implications for preventing coronary heart disease during the prediabetic state.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.10.001

Insulin resistance in non-diabetic subjects is associated with increased incidence of myocardial infarction and death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.10.001

PPARgamma and atherosclerosis: effects on cell growth and movement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.10.001

Control of vascular cell proliferation and migration by PPAR-gamma: a new approach to the macrovascular complications of diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.10.001

Pioglitazone reduces smooth muscle cell density of rat carotid arterial intima induced by balloon catheterization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.10.001

Characterization of an inhibitory effect of pioglitazone on balloon-injured vascular smooth muscle cell growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.10.001

Rat carotid artery dilation by PTCA balloon catheter induces neointima formation in presence of IEL rupture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.10.001

Cardiovascular risk factors associated with insulin resistance cluster in families with early-onset coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.10.001

Thiazolidinediones down-regulate plasminogen activator inhibitor type 1 expression in human vascular endothelial cells: A possible role for PPARgamma in endothelial function.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.10.001

Endothelial Dysfunction and Collagen Accumulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.10.001

Expression and function of PPARgamma in rat and human vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.10.001

Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.10.001

Fasting insulin levels independently associated with coronary heart disease in non-diabetic Turkish men and women.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.10.001

Neointimal hyperplasia after arterial injury is increased in a rat model of non-insulin-dependent diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.10.001

Modulation of vascular inflammation in vitro and in vivo by peroxisome proliferator-activated receptor-gamma activators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.10.001

Expression of endothelial factors after arterial injury in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.10.001

Endothelial NO synthase is increased in regenerating endothelium after denuding injury of the rat aorta

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.10.001

Insulin resistance syndrome predicts the risk of coronary heart disease and stroke in healthy middle-aged men: the 22-year follow-up results of the Helsinki Policemen Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.10.001

Genentech discloses safety concerns over Avastin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.10.001

Adenovirus-mediated VEGF(165) gene transfer enhances wound healing by promoting angiogenesis in CD1 diabetic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.10.001

Intimal injury and regrowth in the rabbit aorta; medial smooth muscle cells as a source of neointima

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.10.001

Hyperinsulinemia during oral glucose tolerance test is associated with increased neointimal tissue proliferation after coronary stent implantation in nondiabetic patients: a serial intravascular ultrasound study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.10.001

Impact of insulin resistance on neointimal tissue proliferation after coronary stent implantation. Intravascular ultrasound studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.10.001

Regulation of macrophage gene expression by peroxisome-proliferator-activated receptor gamma: implications for cardiovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.10.001

PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.10.001

Role of hyperinsulinemia in atherosclerotic coronary arterial disease: studies of semi-quantitative coronary angiography.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.10.001

Impaired glucose tolerance, type 2 diabetes, and carotid wall thickness: the Insulin Resistance Atherosclerosis Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.10.001

The thiazolidinedione rosiglitazone (BRL-49653) lowers blood pressure and protects against impairment of endothelial function in Zucker fatty rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.10.001

Reactive oxygen and NF-kappaB in VEGF-induced migration of human vascular smooth muscle cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.10.001

Troglitazone improves endothelial dysfunction in patients with insulin resistance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.10.001

Peroxisome proliferator-activated receptor-gamma agonists increase vascular endothelial growth factor expression in human vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.10.001

10.1016/J.VPH.2006.10.001

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17141574%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

1 reference